Bioengineer Gang Bao uses gene editing to repair up to 40 percent of bone marrow cells from patients
Scientists have successfully used gene editing to repair 20 to 40 percent of stem and progenitor cells taken from the peripheral blood of patients with sickle cell disease, according to Rice University bioengineer Gang Bao.
Bao, in collaboration with Baylor College of Medicine, Texas Children’s Hospital and Stanford University, is working to find a cure for the hereditary disease. A single DNA mutation causes the body to make sticky, crescent-shaped red blood cells that contain abnormal hemoglobin and can block blood flow in limbs and organs.
In his talk at the annual American Association for the Advancement of Science meeting in Austin Feb. 16, Bao revealed results from a series of tests to see whether CRISPR/Cas9-based editing can fix the mutation. His presentation was part of a scientific session titled “Gene Editing and Human Identity: Promising Advances and Ethical Challenges.”
“Sickle cell disease is caused by a single mutation in the beta-globin gene (in the stem cell’s DNA),” he said. “The idea is to correct that particular mutation, and then stem cells that have the correction would differentiate into normal blood cells, including red blood cells. Those will then be healthy blood cells.”
Bao’s lab collaborated with Vivien Sheehan, an assistant professor of pediatrics and hematology at Baylor and a member of the sickle cell program at Texas Children’s, to collect stem and progenitor cells (CD34-positive cells) from patients with the disease. These were then edited in the Bao lab with CRISPR/Cas9 together with a custom template, a piece of DNA designed to correct the mutation.
The gene-edited cells were injected into the bone marrow of immunodeficient mice and tested after 19 weeks to see how many retained the edit. “The rate of repair remained stable, which is great,” Bao said. This engraftment study was carried out in the lab of Matt Porteus, an associate professor of pediatrics at Stanford.
Another major finding of the study is that the CRISPR/Cas9 system could introduce large alterations to the genes in patients’ cells, in addition to small mutations or deletions. These off-target effects could cause a disease.
The findings, part of an upcoming paper, are a step toward treating sickle cell disease. Obstacles in the way of a cure include optimizing the CRISPR/Cas9 system to eliminate off-target effects, as well as finding a way to further increase the amount of gene-corrected stem cells.
Bao pointed out that researchers still don’t know whether repairing as much as 40 percent of the cells is enough to cure a patient. “We’d like to say, ‘Yes,’” he said, “but we don’t really know yet. That’s something we hope to learn from an eventual clinical trial.”
Learn more: Rice U. reports progress in pursuit of sickle cell cure
The Latest on: Sickle cell disease
[google_news title=”” keyword=”Sickle cell disease” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Sickle cell disease
- Walgreens expands specialty pharmacy with unit dedicated to cell and gene therapieson April 25, 2024 at 6:38 am
Walgreens Boots Alliance (NASDAQ:WBA) has expanded its specialty pharmacy services with a unit dedicated to gene and cell therapy services, the company announced late Wednesday. Effective Aug. 1, the ...
- Researchers publish final results of key clinical trial for gene therapy for sickle cell diseaseon April 25, 2024 at 6:14 am
In a landmark study, an international consortium led by researchers at Children's Hospital of Philadelphia (CHOP) published the final results of a key clinical trial of the gene therapy CASGEVY ...
- CT Up Close: Students with sickle cell disease share key takeaways from visit to NASA space centeron April 25, 2024 at 5:06 am
Last month, about 20 local students with sickle cell disease traveled to NASA’s Goddard Space Center in Maryland to learn more about STEM careers and what they can ...
- 10-year-old survivor uses literature to fight sickle cellon April 24, 2024 at 2:16 pm
Cai Stoudemir is a 10-year-old Author and Sickle Cell Survivor from Milwaukee. She wrote this book, Cai hopes to educate kids and adults about the disease.
- 2025 Cell & Gene Therapy Reimbursement Outlookon April 24, 2024 at 1:00 pm
CMS proposed Medicare’s CGT reimbursement policy matches Medicaid’s sickle cell disease policy, forming a unified government approach.
- Alteration of brain network condition could predict painful vaso-occlusive crisis in patients with sickle cell diseaseon April 24, 2024 at 12:16 pm
A new study led by Indiana University School of Medicine researchers has found that a brain network condition called "explosive synchronization" could be the cause of extreme pain crises in people ...
- Tulsa Woman Organizes Event To Support Caregivers, People Living With Sickle Cell Diseaseon April 24, 2024 at 6:50 am
Velvet Brown Watts gave birth to her son who was diagnosed with Sickle Cell Disease. She said it’s been a challenging journey, but now she is working to raise awareness of this blood disorder within ...
- Vertex jumps to TreeFrog to enhance production of Type 1 diabetes cell therapy candidateson April 24, 2024 at 4:25 am
Following success in cystic fibrosis and sickle cell disease, Vertex’s next big leap is Type 1 diabetes (T1D). | Following success in cystic fibrosis and sickle cell disease, Vertex’s next big leap is ...
- Young New Orleans sickle cell patient is leaving pain behind after a bone marrow transplanton April 22, 2024 at 5:44 am
At only 12 years old, Kelsey Farris already has endured periods of searing pain, endless rounds of medical tests and several lengthy stays at Children’s Hospital in New Orleans. But ...
- Jinja Hospital aims at genetic screening to tame sickle cell diseaseon April 21, 2024 at 6:01 am
Jinja Regional Referral Hospital (JRRH) authorities have announced plans to start genetic screening among couples ...
via Bing News